SINGAPORE September 2023 : CellResearch Corporation Appoints Troels Jordansen as CEO of CellResearch Therapeutics (CRT)…

SINGAPORE October 19, 2022: Dr Andrew Boulton joins CellResearch Corporation’s Therapeutics Scientific Advisory Board to…

SINGAPORE 16 September 2022: CellResearch Corporation (CRC) announces positive results of Phase I study for CorLiCyte®…

SINGAPORE 25th August 2022:Dr Paul Kemp, lead inventor of Apligraf® the first FDA-approved multi-cell therapy,…

SINGAPORE July 19, 2022: CellResearch Corporation (“CRC”), a Singapore biotech company, specialising in stem cell…

SINGAPORE March 1st, 2022: CellResearch Corporation (CRC) has named former Mundipharma and Eirgen executive Olivia…

SINGAPORE September 2022, Los Angeles: CellResearch Corporation (CRC) to present promising new stem cell products…